From Raw Data to Reliable Results. In Clicks, Not Code
Validated pipelines from raw sequencing data to reproducible insights. Automated for reliability, with bioNotebooks for deeper exploration.
End-to-End
Bioinformatics Variant Classification Cohort Analytics
See how it works
(No credit card required. Start in minutes.)
Meet BioMind, our next-level BioAgents layer Pan.bio is the AI-powered, end-to-end genomics platform connecting bioinformatics workflows, variant interpretation, and patient cohort data, all in one place. Built privacy-first with in-country deployment and HIPAA, GDPR, SOC 2, and ISO 27001 compliance baked into the architecture.
Platform
One Platform.
Every Step of
Genomic Analysis.
Four products. One AI copilot. Built to remove the seams between sequencing, interpretation, and cohort work.
Explore. Experiment. Standardize.
A plug-and-play notebook environment where BioMind translates your thoughts to code and helps turn one-off discoveries into reusable collaborative analyses. You are welcome to park BioMind, jump into the driver's seat, and write code yourself.
Clinical Variant Interpretation & Classification
Guideline-aware clinical variant classification powered by ACMG/AMP, CanVIG, ACGS, and ClinGen. AI-assisted, human-controlled.
A Marketplace for Real-World Patient Data
Connecting hospitals and labs with pharma and biotech researchers. Unlock underrepresented populations while keeping data under provider ownership at every step.
Solutions
Built for how you work
Five teams. One platform. Tailored to each.
FASTQ
Align
Analyze
Results
Research Labs & Academia
Accelerate Collaborative Genomics & Bioinformatics for Coders and Non-Coders
Validated pipelines and AI-assisted notebooks your team can utilize, extend, and share for reproducible analysis. Hit the ground running with your analysis whether you are a coder or a non-coder.
Learn More
BRCA2Chr 13q13.1
c.5946del
PVS1PM2PP3
87
PATHOGENIC Clinical Diagnostic Labs
Turn Variant Interpretation from Hours into Minutes
Guideline-aware classification grounded in ACMG/AMP, CanVIG, ACGS, and ClinGen with AI assistance for the hard cases.
Learn More
MENA
E. Asia
EUR
E. Africa
Cohort
Pharma & Biotech R&D
Access Real-World Cohorts You Can't Find Anywhere Else
Population-specific patient data from MENA and East Asia, assembled in weeks, not months.
Learn More
Monthly Data Revenue
$0M
+34% YoY
Hospitals & Healthcare
Turn Existing Genomic Data into a Revenue Stream
Monetize de-identified clinical data without losing ownership, jurisdiction, or compliance.
Learn More
Genomics Lab
Live
Clinical Core
Live
Research Unit
Live
Bioinformatics Service Providers
Standardize Service Delivery Across Every Client
Reproducible workflows, multi-tenant isolation, and a unified AI layer to scale your operations.
Learn More
Our Reach
A growing global community
Trusted by scientists from leading research labs, hospitals, and clinical institutions worldwide.
Why Pan.bio
Built for advanced genomics
Everything an advanced genomics operation needs, privacy, access, and intelligence, in one platform.
Data Sovereignty & Privacy
Deploy on your country’s compliant cloud or on-premise. Data never leaves your jurisdiction.
Built for Underrepresented Populations
Population-specific cohorts and references for MENA and East Asia, populations missing from every major public database.
No-Code Accessibility
Run validated pipelines through a clean interface, or describe what you need to BioMind in plain English.
End-to-End Coverage
Sequencing → pipelines → variant interpretation → clinical reports → cohort discovery, all in one platform.
One AI, Every Application
BioMind is a unified AI copilot that adapts to every product, not multiple separate bots bolted on.
Compliance as Architecture
HIPAA, GDPR, SOC 2 Type 2, and ISO 27001 enforced at the infrastructure level, not as documentation your team manages.
About Pan.bio
Built to translate the
language of life
Pan.bio exists to empower scientists to transform genomic data into scientific breakthroughs. We build the AI-powered, end-to-end platform that bridges the distance between raw sequences and world-changing insights, making genomic research faster, more accurate, and accessible to teams who've been left out of the global research conversation for too long.
Our focus on underrepresented populations isn't a marketing line, it's the reason we exist. From MENA breast cancer research to Pan-Arab diabetes cohorts, we're building the infrastructure that lets clinicians, researchers, and pharma teams generate the genomic insights their populations have been missing from for decades.
"We're not just building software, we're building equity in genomics."
HIPAA PHI safeguards
GDPR EU data privacy
SOC 2 Trust services criteria
ISO Infosec management
Enforced at the infrastructure level, your data stays in your jurisdiction, always.
0
researchers trust Pan.bio to power their genomic discovery
No credit card required · Start in minutes